Zirabev

Pfizer Laboratories Div Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: Jul 21, 2026
Approval ID: aa27acbd-d117-4350-aeee-17bc2e2c0ca4
Products: 2 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ZIRABEV safely and effectively. See full prescribing information for ZIRABEV. ZIRABEV™ (bevacizumab-bvzr) injection, for intravenous use Initial U.S. Approval: 2019 ZIRABEV (bevacizumab-bvzr) is biosimilar to AVASTIN (bevacizumab).

Quick Stats

Total Products2

Labelers2

Label Sections26

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.